Assessment of risk for photocarcinogenesis: regulatory reviewer viewpoint.
Osterberg
R E
RE
Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD, USA.
Szarfman
A
A
D000818:Animals; D002273:Carcinogens / Q000633:toxicity; D003043:Cocarcinogenesis; D006801:Humans; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000209:etiology*; D013472:Sunlight / Q000009:adverse effects*; D014466:Ultraviolet Rays / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D002273:Carcinogens